Your browser doesn't support javascript.
loading
Successful hematopoietic stem cell transplantation in a 4-1BB deficient patient with EBV-induced lymphoproliferation.
Wildermann, Christine; Alosaimi, Mohammed; Liebenehm, Sophie; Jacobsen, Eva-Maria; Barth, Thomas F E; Möller, Peter; Debatin, Klaus-Michael; Schulz, Ansgar; Sirin, Mehtap; Abosoudah, Ibraheem F; Alkuraya, Fowzan S; Geha, Raif S; Hönig, Manfred.
Afiliación
  • Wildermann C; Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Germany. Electronic address: christine.wildermann@uniklinik-ulm.de.
  • Alosaimi M; Department of Pediatrics, King Saudi University, Riyadh, Saudi Arabia; Division of Immunology, Boston Children's Hospital and Department of Pediatrics Harvard Medical School, Boston, MA, USA.
  • Liebenehm S; Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Germany.
  • Jacobsen EM; Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Germany.
  • Barth TFE; Department of Pathology, University Medical Center Ulm, Germany.
  • Möller P; Department of Pathology, University Medical Center Ulm, Germany.
  • Debatin KM; Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Germany.
  • Schulz A; Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Germany.
  • Sirin M; Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Germany.
  • Abosoudah IF; Department of Oncology, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia.
  • Alkuraya FS; Department of Genetics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Geha RS; Division of Immunology, Boston Children's Hospital and Department of Pediatrics Harvard Medical School, Boston, MA, USA.
  • Hönig M; Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Germany.
Clin Immunol ; 222: 108639, 2021 01.
Article en En | MEDLINE | ID: mdl-33259966
Complete remission from recurrent EBV-positive lymphoma is not mandatory before HSCT to achieve long-term cure in a patient suffering from a recently described immunodeficiency affecting the T-cell coactivation molecule 4-1BB.
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfoma de Células B / Trasplante de Células Madre Hematopoyéticas / Infecciones por Virus de Epstein-Barr / Ligando 4-1BB / Miembro 9 de la Superfamilia de Receptores de Factores de Necrosis Tumoral Límite: Child / Humans / Male Idioma: En Revista: Clin Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfoma de Células B / Trasplante de Células Madre Hematopoyéticas / Infecciones por Virus de Epstein-Barr / Ligando 4-1BB / Miembro 9 de la Superfamilia de Receptores de Factores de Necrosis Tumoral Límite: Child / Humans / Male Idioma: En Revista: Clin Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2021 Tipo del documento: Article